NOBIVAC® Feline 1-HCP+FeLV | Merck Animal Health USA
WEBNobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats 1. Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia 61-63.
NOBIVAC® Feline 1-HCP - Merck Animal Health USA
WEBNobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats 1. Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia 62-63; Non-adjuvanted formula; Optimal choice for healthy indoor cats
MSD Animal Health's Ground-breaking FeLV Vaccine
WEB1 day ago · The NOBIVAC NXT FeLV vaccine is labeled effective against persistent viremia and is indicated for the vaccination of cats 8 weeks of age or older against FeLV. According to the label and recommendations from the American Association of Feline Practitioners (AAFP), the vaccine should be administered in 2 doses, 3- to 4-weeks apart.
Nobivac Feline 1-HCP+FeLV for Animal Use - Drugs.com
WEBAug 26, 2024 · Nobivac Feline 1-HCP+FeLV Indications. This product has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, panleukopenia and feline leukemia viruses. Duration of Immunity against feline leukemia virus is at least 2 years.
Nobivac Feline 1-HCPCh + FeLV Vaccine - Covetrus
WEBNobivac Feline 1-HCPCh+FeLV is a core vaccine that works to protect cats from several viruses (rhinotracheitis, calicivirus, and panleukopenia), along with feline leukemia and chlamydophila felis.
New vaccine protects against feline leukemia virus - dvm360
WEB19 hours ago · Merck Animal Health announced the expansion of the recently USDA-approved NOBIVAC NXT vaccination platform to include a solution against feline leukemia virus (FeLV)—one of the most common feline infectious diseases. 1 NOBIVAC NXT FeLV is a nonadjuvanted, low volume 0.5 mL dose vaccination that uses the immune system’s natural strengths to preserve comfort and safety. 1,2 The vaccine is ...
- [PDF]
MERCK ANIMAL HEALTH
WEBMar 23, 2018 · Nobivac Feline 1-HCP vaccine is a modified live virus vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses. s (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent fe.
Nobivac Feline 1-HCP+FeLV, Vaccine, 25 x 1 Single Doses - Jeffers
WEBThe Nobivac® Feline 1-HCP+FeLV vaccine provides dual protection against feline leukemia, rhinotracheitis, calicivirus, and panleukopenia. Suitable for cats 9 weeks and older, it protects against feline leukemia for at least two years.
NOBIVAC® FELINE 1-HCP + FeLV - MSD Animal Health South Africa
WEBNobivac ® Feline 1-HCP is a modified live virus vaccine for the vaccination of healthy cats against feline rhinotracheitis, calici virus, and panleukopenia.
Merck Animal Health Announces Expansion of NOBIVAC® NXT
WEB7 hours ago · The Nobivac NXT FeLV vaccine is labeled effective against persistent viremia and is indicated for the vaccination of cats 8 weeks of age or older against FeLV. According to the label and recommendations from the American Association of Feline Practitioners (AAFP), the vaccine should be administered in 2 doses, 3- to 4-weeks apart.